Cargando…

Ki-67 is a prognostic marker for hormone receptor positive tumors

PURPOSE: To evaluate the utility of Ki67 as a prognostic marker in Luminal B node-negative breast cancer patients. METHODS: We identified 888 patients with invasive breast carcinomas who underwent surgery between 1997 and 2004. Several classical factors were collected: age, tumor size, node involvem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pérez-López, M. E., García-Gómez, J., Alves, M. T., Paradela, A., García-Mata, J., García-Caballero, T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5018017/ https://www.ncbi.nlm.nih.gov/pubmed/26742937 http://dx.doi.org/10.1007/s12094-015-1472-y

Ejemplares similares

Prognostic impact of discrepant Ki67 and mitotic index on hormone receptor-positive, HER2-negative breast carcinoma
por: Rossi, L, et al.
Publicado: (2015)

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer
por: Ali, H R, et al.
Publicado: (2012)

The Ki67 index a prognostic marker in medullary thyroid carcinoma
por: Tisell, L E, et al.
Publicado: (2003)

The Role of Ki67 in Evaluating Neoadjuvant Endocrine Therapy of Hormone Receptor-Positive Breast Cancer
por: Zhang, Ailin, et al.
Publicado: (2021)

Ki-67 as a prognostic marker according to breast cancer molecular subtype
por: Soliman, Nahed A., et al.
Publicado: (2016)

Gastrointestinal Stromal Tumor and Ki-67 as a Prognostic Indicator
por: Kadado, Kevin J, et al.
Publicado: (2022)

Ki-67 labeling index as a prognostic marker in advanced stomach cancer
por: Seo, Sang Hyuk, et al.
Publicado: (2019)

What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?
por: Xie, Shang, et al.
Publicado: (2016)

A comparison of Ki-67 and mitotic count as prognostic markers for metastatic pancreatic and midgut neuroendocrine neoplasms
por: Khan, M S, et al.
Publicado: (2013)

Ki67 expression in breast cancer: Correlation with prognostic markers and clinicopathological parameters in Saudi patients
por: Elkablawy, Mohamed A., et al.
Publicado: (2016)

Ki-67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma
por: Jing, Yue, et al.
Publicado: (2019)

P53 and Ki-67 as prognostic markers in triple-negative breast cancer patients
por: Pan, Yunbao, et al.
Publicado: (2017)

Ki-67, an elusive marker in the prognosis of breast cancer
por: Sood, Neelam
Publicado: (2019)

Ki67/SATB1 ratio is an independent prognostic factor of overall survival in patients with early hormone receptor-positive invasive ductal breast carcinoma
por: Laurinavicius, Arvydas, et al.
Publicado: (2015)

Ki-67 as a Prognostic Biomarker in Invasive Breast Cancer
por: Davey, Matthew G., et al.
Publicado: (2021)

Molecular subtyping of ependymoma and prognostic impact of Ki-67
por: Lim, Ka Young, et al.
Publicado: (2021)

Dynamic chromosomal interactions and control of heterochromatin positioning by Ki‐67
por: van Schaik, Tom, et al.
Publicado: (2022)

Utility of Serum Ki-67 as a Marker for Malignancy in Dogs
por: Estaller, Annkathrin, et al.
Publicado: (2022)

Prognostic value of Ki-67 immunolabelling in primary operable breast cancer.
por: Railo, M., et al.
Publicado: (1993)

Comparison of the value of PCNA and Ki-67 as markers of cell proliferation in ameloblastic tumor
por: Bologna-Molina, Ronell, et al.
Publicado: (2013)

A comparative study between Ki67 positive versus Ki67 negative females with breast cancer: Cross sectional study
por: Bahaddin, Mowafak Masoud
Publicado: (2020)

Ki-67 gene expression
por: Uxa, Sigrid, et al.
Publicado: (2021)

Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
por: Ács, Balázs, et al.
Publicado: (2017)

Spotlight on Ki67 as a prognostic marker in early breast cancer: all that glitters may not be gold
por: Maltoni, Roberta, et al.
Publicado: (2020)

Prognostic Investigations of Expression Level of Two Genes FasL and Ki-67 as Independent Prognostic Markers of Human Retinoblastoma
por: Kouzegaran, Samaneh, et al.
Publicado: (2017)

To Ki or Not to Ki: Re-Evaluating the Use and Potentials of Ki-67 for T Cell Analysis
por: Di Rosa, Francesca, et al.
Publicado: (2021)

The Prognostic Potential of Neurokinin 1 Receptor in Breast Cancer and Its Relationship with Ki-67 Index
por: Al-Keilani, Maha S., et al.
Publicado: (2022)

Recurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
por: Genç, C. G., et al.
Publicado: (2018)

Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
por: Jaros, E., et al.
Publicado: (1992)

Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort
por: Richardsen, Elin, et al.
Publicado: (2017)

Variability of predictive markers (hormone receptors, Her2, Ki67) and intrinsic subtypes of breast cancer in four consecutive years 2015–2018
por: Stevanovic, Lidija, et al.
Publicado: (2019)

The prognostic significance of p63 and Ki-67 expression in myoepithelial carcinoma
por: Jiang, You-Hua, et al.
Publicado: (2012)

Diagnostic and Prognostic Value Of Ki67 Proliferation Fraction in Serous Effusions
por: Schönherr, Alexandra, et al.
Publicado: (2004)

Prognostic and predictive value of Ki-67 in triple-negative breast cancer
por: Wang, Wei, et al.
Publicado: (2016)

Ki67 as a prognostic factor of craniopharyngioma’s recurrence in paediatric population
por: Moszczyńska, Elżbieta, et al.
Publicado: (2020)

The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
por: Zhu, Xiuzhi, et al.
Publicado: (2020)

Prognostic and Clinicopathological Value of Ki-67 in Melanoma: A Meta-Analysis
por: Liu, Qixin, et al.
Publicado: (2021)

Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma
por: Meng, Yu, et al.
Publicado: (2022)

Prognostic value of Ki-67 in nasopharyngeal carcinoma: a meta-analysis
por: Li, Yulin, et al.
Publicado: (2021)

Prognostic impact of Ki‐67 proliferative index in resectable pancreatic ductal adenocarcinoma
por: Pergolini, I., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_avk5mst5apcsgln13m0shn6ar7